Skip to main content
Top

Diabetologia

Issue 3/1999

Content (24 Articles)

Articles

Type I (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption

R. B. Elliott, D. P. Harris, J. P. Hill, N. J. Bibby, H. E. Wasmuth

Short communication

Uncoupling protein-3 gene expression: reduced skeletal muscle mRNA in obese humans during pronounced weight loss

H. Esterbauer, H. Oberkofler, G. Dallinger, D. Breban, E. Hell, F. Krempler, W. Patsch

Short communication

Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals

M. L. Goalstone, K. Wall, J. W. Leitner, T. Kurowski, N. Ruderman, S. J Pan, J. L. Ivy, D. E. Moller, B. Draznin

Short communication

Protein metabolism in glucagonoma

R. Barazzoni, M. Zanetti, A. Tiengo, P. Tessari

Short communication

Finger and penile tactile sensitivity in sexually functional and dysfunctional diabetic men

D. L. Morrissette, M. K. Goldstein, D. B. Raskin, D. L. Rowland

Short communication

Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

C. G. Schalkwijk, D. C. W. Poland, W. van Dijk, A. Kok, J. J. Emeis, A. M. Dräger, A. Doni, V. W. M. van Hinsbergh, C. D. A. Stehouwer

Short communication

Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients

F. Andreelli, M. Laville, P.-H. Ducluzeau, N. Vega, P. Vallier, Y. Khalfallah, J.-P. Riou, H. Vidal

Short communication

Euglycaemic hyperinsulinaemia does not affect gastric emptying in Type I and Type II diabetes mellitus

M.-F. Kong, P. King, I. A. Macdonald, P. E. Blackshaw, M. Horowitz, A. C. Perkins, E. Armstrong, K. D. Buchanan, R. B. Tattersall

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine